OR WAIT null SECS
September 02, 2022
As winter approaches, the next generation of COVID-19 vaccines are being prepared and scheduled, ready for distribution across Europe and the world.
August 31, 2022
Lonza has introduced X-ray powder diffraction capability at its Monteggio, Switzerland site.
Forecyte Bio and Cytiva will team up to accelerate the development and manufacturing of cell and gene therapies.
August 30, 2022
Emerson’s new gas analysis solutions center, located in Cumbernauld, Scotland, intends to help plants meet sustainability goals.
Thermo Fisher Scientific’s new 300,000 ft² facility, located in Plainville, Mass., will specialize in manufacturing viral vectors.
Scientists have developed a mouse model that could be a promising model system for research into factors affecting mammalian embryonic development and disease.
Novavax’s COVID-19 vaccine, Nuvaxovid, can now be given to adolescents aged 12 to 17 in the UK.
Canvax’s new inorganic pyrophosphate is designed for in-vitro transcription reactions.
August 29, 2022
The European Union publishes long-awaited changes to Annex 1.
Moderna is suing Pfizer and BioNTech for allegedly infringing on patents the company filed from 2010 to 2016.